Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in TKNO — Alpha Teknova, Inc.

CIK 1362033 LONDON, X0
Back to TKNO Full portfolio

Position in TKNO

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$302,732
+$98,545 QoQ
Shares Held
53,298
+28.2% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 80 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TKNO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $11,914,926 across 21 Drug Manufacturers - Specialty & Generic names. TKNO ranks #14 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INDV
Indivior Pharmaceuticals, Inc.
 55,201 $2,264,897
2 ZTS
Zoetis Inc.
 18,470 $1,327,254
3 IRWD
Ironwood Pharmaceuticals Inc
 259,512 $1,092,545
4 BCRX
Biocryst Pharmaceuticals Inc
 90,210 $902,100
5 LQDA
Liquidia Corp
 10,098 $805,113
6 KNSA
Kiniksa Pharmaceuticals International, plc
 11,219 $717,455
7 AMLX
Amylyx Pharmaceuticals, Inc.
 39,241 $704,768
8 XERS
Xeris Biopharma Holdings, Inc.
 82,830 $656,013

All Filings in TKNO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $302,732 53,298
2025-06-30 $204,187 41,586